Andrea Ladanyi

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy.

Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy.

Journal: Frontiers in immunology

Published: May 20, 2026

Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance.

Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance.

Journal: Cancers

Published: May 05, 2026

A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial - Prognostic role of tumor PD-L1 expression.

A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial - Prognostic role of tumor PD-L1 expression.

Journal: Oral oncology

Published: March 02, 2026

Clinical Applications of the Molecular Landscape of Melanoma: Integration of Research into Diagnostic and Therapeutic Strategies.

Clinical Applications of the Molecular Landscape of Melanoma: Integration of Research into Diagnostic and Therapeutic Strategies.

Journal: Cancers

Published: March 18, 2025

Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the IT-MATTERS study.

Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma -the IT-MATTERS study.

Journal: Pathology oncology research : POR

Published: January 17, 2025

Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.

Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.

Journal: Biomolecules

Published: November 05, 2024

Editorial: Pathology and Oncology Research: addressing publication ethics issues.

Editorial: Pathology and Oncology Research: addressing publication ethics issues.

Journal: Pathology oncology research : POR

Published: January 18, 2024

Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma.

Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 08, 2024

p38 Mitogen-Activated Protein Kinase Inhibition of Mesenchymal Transdifferentiated Tumor Cells in Head and Neck Squamous Cell Carcinoma.

p38 Mitogen-Activated Protein Kinase Inhibition of Mesenchymal Transdifferentiated Tumor Cells in Head and Neck Squamous Cell Carcinoma.

Journal: Biomedicines

Published: October 27, 2023

Insights into the Tumor Microenvironment-Components, Functions and Therapeutics.

Insights into the Tumor Microenvironment-Components, Functions and Therapeutics.

Journal: International journal of molecular sciences

Published: June 15, 2023

Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets.

Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets.

Journal: Cells

Published: May 02, 2023

Potential role of type I interferon in the genetic progression of melanoma

Potential role of type I interferon in the genetic progression of melanoma

Journal: Magyar onkologia

Published: April 13, 2023

Showing 1-12 of 50

Last Updated: 09/26/2026